Therapeutic Drug Monitoring Market by Product (Equipment and Consumables), by Drug Class (Antiarrhythmic Drugs, Antiepileptic Drugs, Antibiotic Drugs,Immunosuppressant Drugs, Psychoactive Drugs, Bronchodilator Drugs, and Others), and by End-User(Commercial/Private Labs, Hospital Labs, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 - 2024

Description

The report covers forecast and analysis for the therapeutic drug monitoring market on a global and regional level. The study provides historical data from 2015, 2016, 2017along with a forecast from 2018 to 2024based revenue (USD Billion). The study includes drivers and restraints for the therapeutic drug monitoring market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the therapeutic drug monitoring market on a global level.

In order to give the users of this report a comprehensive view of the therapeutic drug monitoring market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a customer and region segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research& development, regional expansion of major participants involved in the market on a global and regional basis. 

The study provides a decisive view of the therapeutic drug monitoring market by segmenting the market based on customer and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018to 2024. 

On the basis of product type, the global therapeutic drug monitoring market is segmented into equipment and consumables. On the basis of drug class, the market is segmented into antiepileptic drugs, antiarrhythmic drugs, immunosuppressant drugs, antibiotic drugs, bronchodilator drugs, psychoactive drug, and others. On the basis of the end-user segment, the market is segmented into commercial/private labs, hospital lab, and others. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S. Germany, France, UK, China, Japan, India, and Brazil. 

Some key players of the global therapeutic drug monitoring market include F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Siemens Healthcare, Bio-Rad Laboratories Inc., and Danaher Corporation, among others.

This report segments the global therapeutic drug monitoring market as follows:

Global Therapeutic Drug Monitoring Market: ProductType Segment Analysis

• Equipment
• Consumables

Global Therapeutic Drug Monitoring Market: Drug Class Segment Analysis

• Antiepileptic Drugs
• Antiarrhythmic Drugs
• Immunosuppressant Drugs
• Antibiotic Drugs
• Bronchodilator Drugs
• Psychoactive Drugs
• Others

Global Therapeutic Drug Monitoring Market: End-User Segment Analysis

• Commercial/Private Labs
• Hospital Labs
• Others

Global Therapeutic Drug Monitoring Market: Regional Segment Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa

Table Of Content

• Chapter 1. Introduction
  • 1.1. Report description and scope
  • 1.2. Research scope
  • 1.3. Research methodology
    • 1.3.1. Market research process
    • 1.3.2. Market research methodology
•  
• Chapter 2. Executive Summary
  • 2.1. Global Therapeutic Drug Monitoring Market, 2015 - 2024 (USD Billion)
  • 2.2. Global Therapeutic Drug Monitoring Market: Snapshot
•  
• Chapter 3. Therapeutic Drug Monitoring Market - Dynamics
  • 3.1. Introduction
  • 3.2. Market drivers
    • 3.2.1. Global Therapeutic Drug Monitoring Market drivers: Impact analysis
    • 3.2.2. Growing Biopharmaceutical Industry
    • 3.2.3. Growing adoption of Therapeutic Drug Monitoringby healthcare settings
    • 3.2.4. High Capital investment in R&D
  • 3.3. Market Restraints
    • 3.3.1. High cost
    • 3.3.2. Stringent Rules and Regulations
  • 3.4. Opportunities
    • 3.4.1. Technological Advancements
    • 3.4.2. Untapped Markets
  • 3.5. Porter's five forces analysis
    • 3.5.1. Bargaining power of suppliers
    • 3.5.2. Bargaining power of buyers
    • 3.5.3. The threat from new entrants
    • 3.5.4. The threat from new substitutes
    • 3.5.5. Degree of competition
  • 3.6. Market attractiveness analysis
    • 3.6.1. Market attractiveness analysis, by Product Type
    • 3.6.2. Market attractiveness analysis, by Drug Class
    • 3.6.3. Market attractiveness analysis, by End-User
    • 3.6.4. Market attractiveness analysis, by Regional segment
•  
• Chapter 4. Global Therapeutic Drug Monitoring Market- Competitive Landscape
  • 4.1. Company Market Share Analysis
    • 4.1.1. Global Therapeutic Drug Monitoring market: company market share, 2017
  • 4.2. Strategic Development
    • 4.2.1. Acquisitions & Mergers
    • 4.2.2. New Product Launch
    • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
    • 4.2.4. Research and Development, Regional Expansion
•  
• Chapter 5. Global Therapeutic Drug Monitoring Market - Product Type Segment Analysis
  • 5.1. Global Therapeutic Drug Monitoring market: ProductTypeoverview
    • 5.1.1. Global Therapeutic Drug Monitoring market revenue share, byProductType, 2015 and 2025
    • 5.1.2. Global Therapeutic Drug Monitoring market revenue share, by Equipment, 2015 - 2024
    • 5.1.3. Global Therapeutic Drug Monitoring market revenue share, by Consumables, 2015 - 2024
•  
• Chapter 6. Global Therapeutic Drug Monitoring Market - Drug Class Segment Analysis
  • 6.1. Global Therapeutic Drug Monitoring Market: Applicationoverview
    • 6.1.1. Global Therapeutic Drug Monitoring market revenue share, Application, 2015 and 2025
    • 6.1.2. Global Therapeutic Drug Monitoring market revenue share, by Antiarrhythmic Drugs, 2015 - 2024
    • 6.1.3. Global Therapeutic Drug Monitoring market revenue share, by Immunosuppressant Drugs, 2015 - 2024
    • 6.1.4. Global Therapeutic Drug Monitoring market revenue share, by Antibiotic Drugs, 2015 - 2024
    • 6.1.5. Global Therapeutic Drug Monitoring market revenue share, by Bronchodilator Drugs, 2015 - 2024
    • 6.1.6. Global Therapeutic Drug Monitoring market revenue share, by Psychoactive Drugs, 2015 - 2024
    • 6.1.7. Global Therapeutic Drug Monitoring market revenue share, by Others, 2015 - 2024
•  
• Chapter 7. Global Therapeutic Drug Monitoring Market - End-User Segment Analysis
  • 7.1. Global Therapeutic Drug Monitoring Market: End-User overview
    • 7.1.1. Global Therapeutic Drug Monitoring market revenue share, End-User, 2015 and 2025
    • 7.1.2. Global Therapeutic Drug Monitoring market revenue share, by Commercial/Private Labs, 2015 - 2024
    • 7.1.3. Global Therapeutic Drug Monitoring market revenue share, by Hospital Labs, 2015 - 2024
    • 7.1.4. Global Therapeutic Drug Monitoring market revenue share, by Others, 2015 - 2024
•  
• Chapter 8. Global Therapeutic Drug Monitoring Market - Regional Segment Analysis
  • 8.1. Global Therapeutic Drug Monitoring market: Regional overview
    • 8.1.1. Global Therapeutic Drug Monitoring market revenue share, by region, 2015 and 2025
  • 8.2. North America
    • 8.2.1. North AmericaTherapeutic Drug Monitoring market revenue, by Product Type, 2015 - 2024(USD Billion)
    • 8.2.2. North AmericaTherapeutic Drug Monitoring market revenue, by Drug Class, 2015 - 2024(USD Billion)
    • 8.2.3. North AmericaTherapeutic Drug Monitoring market revenue, by End-User, 2015 - 2024(USD Billion)
    • 8.2.4. The U.S.
      • 8.2.4.1. The U.S. Therapeutic Drug Monitoring market revenue, by Product Type, 2015 - 2024(USD Billion)
      • 8.2.4.2. The U.S. Therapeutic Drug Monitoring market revenue, by Drug Class, 2015 - 2024(USD Billion)
      • 8.2.4.3. The U.S. Therapeutic Drug Monitoring market revenue, by End-User, 2015 - 2024(USD Billion)
  • 8.3. Europe
    • 8.3.1. EuropeTherapeutic Drug Monitoring market revenue, by Product Type, 2015 - 2024(USD Billion)
    • 8.3.2. EuropeTherapeutic Drug Monitoring market revenue, by Drug Class, 2015 - 2024(USD Billion)
    • 8.3.3. EuropeTherapeutic Drug Monitoring market revenue, by End-User, 2015 - 2024(USD Billion)
    • 8.3.4. UK
      • 8.3.4.1. UKTherapeutic Drug Monitoring market revenue, by Product Type, 2015 - 2024(USD Billion)
      • 8.3.4.2. UKTherapeutic Drug Monitoring market revenue, by Drug Class, 2015 - 2024(USD Billion)
      • 8.3.4.3. UKTherapeutic Drug Monitoring market revenue, by End-User, 2015 - 2024(USD Billion)
    • 8.3.5. Germany
      • 8.3.5.1. GermanyTherapeutic Drug Monitoring market revenue, by Product Type, 2015 - 2024(USD Billion)
      • 8.3.5.2. GermanyTherapeutic Drug Monitoring market revenue, by Drug Class, 2015 - 2024(USD Billion)
      • 8.3.5.3. GermanyTherapeutic Drug Monitoring market revenue, by End-User, 2015 - 2024(USD Billion)
    • 8.3.6. France
      • 8.3.6.1. FranceTherapeutic Drug Monitoring market revenue, by Product Type, 2015 - 2024(USD Billion)
      • 8.3.6.2. FranceTherapeutic Drug Monitoring market revenue, by Drug Class, 2015 - 2024(USD Billion)
      • 8.3.6.3. FranceTherapeutic Drug Monitoring market revenue, by End-User, 2015 - 2024(USD Billion)
  • 8.4. Asia Pacific
    • 8.4.1. Asia PacificTherapeutic Drug Monitoring market revenue, by Product Type, 2015 - 2024(USD Billion)
    • 8.4.2. Asia PacificTherapeutic Drug Monitoring market revenue, by Drug Class, 2015 - 2024(USD Billion)
    • 8.4.3. Asia PacificTherapeutic Drug Monitoring market revenue, by End-User, 2015 - 2024(USD Billion)
    • 8.4.4. China
      • 8.4.4.1. ChinaTherapeutic Drug Monitoring market revenue, by Product Type, 2015 - 2024(USD Billion)
      • 8.4.4.2. ChinaTherapeutic Drug Monitoring market revenue, by Drug Class, 2015 - 2024(USD Billion)
      • 8.4.4.3. ChinaTherapeutic Drug Monitoring market revenue, by End-User, 2015 - 2024(USD Billion)
    • 8.4.5. Japan
      • 8.4.5.1. JapanTherapeutic Drug Monitoring market revenue, by Product Type, 2015 - 2024(USD Billion)
      • 8.4.5.2. JapanTherapeutic Drug Monitoring market revenue, by Drug Class, 2015 - 2024(USD Billion)
      • 8.4.5.3. JapanTherapeutic Drug Monitoring market revenue, by End-User, 2015 - 2024(USD Billion)
    • 8.4.6. India
      • 8.4.6.1. IndiaTherapeutic Drug Monitoring market revenue, by Product Type, 2015 - 2024(USD Billion)
      • 8.4.6.2. IndiaTherapeutic Drug Monitoring market revenue, by Drug Class, 2015 - 2024(USD Billion)
      • 8.4.6.3. IndiaTherapeutic Drug Monitoring market revenue, by End-User, 2015 - 2024(USD Billion)
  • 8.5. Latin America
    • 8.5.1. Latin AmericaTherapeutic Drug Monitoring market revenue, by Product Type, 2015 - 2024(USD Billion)
    • 8.5.2. Latin AmericaTherapeutic Drug Monitoring market revenue, by Drug Class, 2015 - 2024(USD Billion)
    • 8.5.3. Latin AmericaTherapeutic Drug Monitoring market revenue, by End-User, 2015 - 2024(USD Billion)
    • 8.5.4. Brazil
      • 8.5.4.1. BrazilTherapeutic Drug Monitoring market revenue, by Product Type, 2015 - 2024(USD Billion)
      • 8.5.4.2. BrazilTherapeutic Drug Monitoring market revenue, by Drug Class, 2015 - 2024(USD Billion)
      • 8.5.4.3. BrazilTherapeutic Drug Monitoring market revenue, by End-User, 2015 - 2024(USD Billion)
  • 8.6. The Middle East and Africa
    • 8.6.1. The Middle East and AfricaTherapeutic Drug Monitoring market revenue, by Product Type, 2015 - 2024(USD Billion)
    • 8.6.2. The Middle East and AfricaTherapeutic Drug Monitoring market revenue, by Drug Class, 2015 - 2024(USD Billion)
    • 8.6.3. The Middle East and AfricaTherapeutic Drug Monitoring market revenue, by End-User, 2015 - 2024(USD Billion)
•  
• Chapter 9. Company Profile
  • 9.1. F. Hoffmann-La Roche AG
    • 9.1.1. Overview
    • 9.1.2. Financials
    • 9.1.3. Therapy portfolio
    • 9.1.4. Business strategy
    • 9.1.5. Recent developments
  • 9.2. Siemens Healthcare
    • 9.2.1. Overview
    • 9.2.2. Financials
    • 9.2.3. Therapy portfolio
    • 9.2.4. Business strategy
    • 9.2.5. Recent developments
  • 9.3. Thermo Fisher Scientific
    • 9.3.1. Overview
    • 9.3.2. Financials
    • 9.3.3. Therapy portfolio
    • 9.3.4. Business strategy
    • 9.3.5. Recent developments
  • 9.4. Bio-Rad Laboratories Inc.
    • 9.4.1. Overview
    • 9.4.2. Financials
    • 9.4.3. Therapy portfolio
    • 9.4.4. Business strategy
    • 9.4.5. Recent developments
  • 9.5. Danaher Corporation
    • 9.5.1. Overview
    • 9.5.2. Financials
    • 9.5.3. Therapy portfolio
    • 9.5.4. Business strategy
    • 9.5.5. Recent developments

Methodology

Free Analysis

Therapeutic drug monitoring(TDM)has several benefits for patients who are on regular medication or suffering from illnesses, infections, accidents, surgeries, and physical stresses. It involves regular measurement of medicines and drugs in order to maintain a constant concentration of medications in the bloodstream. These days therapeutic drug monitoring (TDM) has become a highly essential and vital method to avoid drug toxicity. Adverse drug reactions occur due to inaccurate dosage and, sometimes, lead to critical medical conditions and, in many cases, lead to death, if not managed properly. 

Growing demand for therapeutic drug monitoring around the world for organized disease treatment is the key driver for the global therapeutic drug monitoring market. In addition, the growing geriatric population and the rapid increase in the prevalence of cancer and diabetes are further expected to augment the growth of this market in the upcoming years. However, the high cost of therapeutic drug monitoring, strict government regulations, and lack of trained resources are the major factors restraining the growth of the therapeutic drug monitoring market. On the other hand, rapid technological advancements in therapeutics drug monitoring solutions are likely to offer prospective opportunities in the forecast timeframe.

On the basis of product type, the market is segmented into equipment and consumables. Among these, the equipment segment was the highest revenue grosser in the year 2017.

On the basis of drug class, the market is segmented into antiarrhythmic drugs, antibiotic drugs, immunosuppressant drugs, bronchodilator drugs, psychoactive drug, antiepileptic drugs, and others.

The end-users in the therapeutic drug monitoring market are commercial/private labs, hospital labs, and others. The commercial/private companies dominated the market and accounted for the largest share in 2017. The growth of this segment is primarily credited to the growing awareness among people regarding the benefits of therapeutic drug monitoring. The hospital lab segment is projected to grow at the highest CAGR in the forecast span.

Based on geography, the global therapeutic drug monitoring market is divided into five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America was the leading region in terms of revenue generation in 2017. Europe was the second largest market followed by the Asia Pacific. The Asia Pacific therapeutic drug monitoring market was the fastest growing market in 2017 and is anticipated to grow at a significant pace in the following years. The growth in this region can be attributed to the rapid development of healthcare infrastructure and heightened corporate investments in the healthcare sector. The Middle East and African and Latin American regions are expected to experience moderate growth in the therapeutic drug monitoring market in the years to come. 

Some of the major players in the global therapeutic drug monitoring market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Siemens Healthcare, Bio-Rad Laboratories Inc., and Danaher Corporation, among others.